Search

Your search keyword '"Lupinek C"' showing total 195 results

Search Constraints

Start Over You searched for: Author "Lupinek C" Remove constraint Author: "Lupinek C"
195 results on '"Lupinek C"'

Search Results

2. Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFOREA‐ARIA‐EPOS‐AIRWAYS ICP statement

3. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

4. Are allergic multimorbidities and IgE polysensitization associated with the persistence or re-occurrence of foetal type 2 signalling? The MeDALL hypothesis

8. Isolation of a high‐affinity Bet v 1‐specific IgG‐derived ScFv from a subject vaccinated with hypoallergenic Bet v 1 fragments

9. MeDALL (Mechanisms of the Development of ALLergy): an integrated approach from phenotypes to systems medicine

13. Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement

14. PreDicta chip-based high resolution diagnosis of rhinovirus-induced wheeze

15. Intranasal administration of allergen increases specific IgE whereas intranasal omalizumab does not increase serum IgE levels : a pilot study

16. Paving the way of systems biology and precision medicine in allergic diseases: the MeDALL success story: Mechanisms of the Development of ALLergy; EU FP7-CP-IP; Project No: 261357; 2010-2015

17. The asthma-rhinitis multimorbidity is associated with IgE polysensitization in adolescents and adults

19. IgE, IgG4 and IgA specific to Bet v 1-related food allergens do not predict oral allergy syndrome

20. HELMINTH INFECTION AND ALLERGIC SENSITIZATION IN ESWATI CHILDREN

23. Mechanisms of the Development of Allergy (MeDALL): Introducing novel concepts in allergy phenotypes

24. Paving the way of systems biology and precision medicine in allergic diseases: the MeDALL success story Mechanisms of the Development of ALLergy; EUFP7-CP-IP; Project No: 261357; 2010-2015

25. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

26. Intranasal administration of allergen increases specific IgE whereas intranasal omalizumab does not increase serum IgE levels-A pilot study

27. Pooling birth cohorts in allergy and asthma: European union-funded initiatives-a MeDALL, CHICOS, ENRIECO, and GALEN joint paper: CHICOS study group ENRIECO study group GA2LEN study group

28. Paving the way of systems biology and precision medicine in allergic diseases: the MeDALL success story: Mechanisms of the Development of ALLergy; EU FP7-CP-IP; Project No: 261357; 2010-2015

29. ARIA 2016 : Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

30. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle.

31. ARIA 2016

32. Paving the way of systems biology and precision medicine in allergic diseases

33. Paving the way of systems biology and precision medicine in allergic diseases: the MeDALL success story: Mechanisms of the Development of ALLergy; EU FP7-CP-IP; Project No: 261357; 2010-2015

34. Paving the way of systems biology and precision medicine in allergic diseases: the MeDALL success story: Mechanisms of the Development of ALLergy; EU FP7-CP-IP; Project No: 261357; 2010-2015

35. ARIA 2016:Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

36. Paving the way of systems biology and precision medicine in allergic diseases: the Me DALL success story

37. Are allergic multimorbidities and IgE polysensitization associated with the persistence or re-occurrence of foetal type 2 signalling?: The MeDALL hypothesis

38. Are allergic multimorbidities and IgE polysensitization associated with the persistence or re-occurrence of foetal type 2 signalling?: The MeDALL hypothesis

39. Are allergic multimorbidities and IgE polysensitization associated with the persistence or re-occurrence of foetal type 2 signalling? The MeDALL hypothesis

41. MeDALL (Mechanisms of the Development of ALLergy): an integrated approach from phenotypes to systems medicine

44. MeDALL (Mechanisms of the Development of ALLergy): An integrated approach from phenotypes to systems medicine,MeDALL (Mechanizmy powstawania alergii): Zintegrowane podejście - od fenotypów do medycyny systemowej

46. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

47. MeDALL (Mechanisms of the Development of ALLergy): An integrated approach from phenotypes to systems medicine | MeDALL (Mechanizmy powstawania alergii): Zintegrowane podejście - od fenotypów do medycyny systemowej

49. Evolution Toward Chip-Based Arrays in the Laboratory Diagnosis of Human Allergic Disease.

Catalog

Books, media, physical & digital resources